Dana Hyassat

836 total citations
30 papers, 563 citations indexed

About

Dana Hyassat is a scholar working on Endocrinology, Diabetes and Metabolism, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, Dana Hyassat has authored 30 papers receiving a total of 563 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Pathology and Forensic Medicine and 4 papers in Surgery. Recurrent topics in Dana Hyassat's work include Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers), Diabetes Treatment and Management (6 papers) and Vitamin D Research Studies (5 papers). Dana Hyassat is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers), Diabetes Treatment and Management (6 papers) and Vitamin D Research Studies (5 papers). Dana Hyassat collaborates with scholars based in Jordan, Bahrain and Australia. Dana Hyassat's co-authors include Kamel Ajlouni, Yousef Khader, Anwar Batieha, Hashem Jaddou, Mohammed El‐Khateeb, Mohammad Khateeb, Yacoub M. Irshaid, Nidal Younes, Zainab Lafi and Mohammed El‐Khateeb and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Medicine.

In The Last Decade

Dana Hyassat

29 papers receiving 543 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dana Hyassat Jordan 13 154 145 96 83 80 30 563
Waleed Tamimi Saudi Arabia 14 159 1.0× 198 1.4× 139 1.4× 65 0.8× 132 1.6× 41 782
Zahid Naeem Pakistan 11 169 1.1× 74 0.5× 71 0.7× 23 0.3× 67 0.8× 24 484
V. Raman Kutty India 10 185 1.2× 59 0.4× 59 0.6× 25 0.3× 62 0.8× 25 506
Fernando de la Guía-Galipienso Spain 8 36 0.2× 135 0.9× 75 0.8× 46 0.6× 73 0.9× 25 586
John Barragry United Kingdom 12 58 0.4× 211 1.5× 79 0.8× 79 1.0× 54 0.7× 33 618
Osama Moharram Saudi Arabia 9 73 0.5× 309 2.1× 140 1.5× 55 0.7× 153 1.9× 9 611
Khalid S Aljabri Saudi Arabia 9 314 2.0× 97 0.7× 41 0.4× 14 0.2× 90 1.1× 43 662
Lucy Fike United States 8 25 0.2× 223 1.5× 84 0.9× 54 0.7× 61 0.8× 22 518
SV Madhu India 13 345 2.2× 96 0.7× 70 0.7× 11 0.1× 75 0.9× 73 707
Benjamin J. Harshfield United States 8 122 0.8× 283 2.0× 135 1.4× 22 0.3× 203 2.5× 10 816

Countries citing papers authored by Dana Hyassat

Since Specialization
Citations

This map shows the geographic impact of Dana Hyassat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dana Hyassat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dana Hyassat more than expected).

Fields of papers citing papers by Dana Hyassat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dana Hyassat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dana Hyassat. The network helps show where Dana Hyassat may publish in the future.

Co-authorship network of co-authors of Dana Hyassat

This figure shows the co-authorship network connecting the top 25 collaborators of Dana Hyassat. A scholar is included among the top collaborators of Dana Hyassat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dana Hyassat. Dana Hyassat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Farah, Randa, et al.. (2024). Risk factors for chronic kidney disease in middle eastern patients with type 2 diabetes mellitus: A cross-sectional study using the KDIGO classification. Journal of Diabetes and its Complications. 38(5). 108740–108740. 3 indexed citations
2.
Abufaraj, Mohammad, et al.. (2023). The prevalence of overactive bladder and its impact on the quality of life: A cross-sectional study. Arab Journal of Urology. 22(1). 39–47. 5 indexed citations
3.
Hyassat, Dana, et al.. (2023). Control of diabetes, hypertension, and dyslipidemia in Jordan: a cross-sectional study. Annals of Medicine and Surgery. 85(3). 439–445. 1 indexed citations
4.
Hyassat, Dana, Mohammad El‐khateeb, Mousa Abujbara, et al.. (2023). Post-COVID-19 syndrome among healthcare workers in Jordan. Eastern Mediterranean Health Journal. 29(4). 247–253. 9 indexed citations
5.
Juweid, Malik E., Akram Al‐Ibraheem, Mousa Abujbara, et al.. (2023). Degenerative lumbar changes have a statistically significant but small effect on trabecular bone score (TBS)-adjusted fracture risk (FRAX). Medicine. 102(47). e36082–e36082. 2 indexed citations
6.
Hyassat, Dana, et al.. (2023). The prevalence of diabetes distress among patients with type 2 diabetes in Jordan. Journal of Taibah University Medical Sciences. 18(6). 1237–1243. 9 indexed citations
7.
Hyassat, Dana, et al.. (2022). Prevalence and Correlates of Hypophosphatemia Among Type 2 diabetic patients attending the National Center for Diabetes, Endocrinology and genetics (NCDEG). Annals of Medicine and Surgery. 78. 103770–103770. 6 indexed citations
8.
Hyassat, Dana, et al.. (2022). Dyslipidemia among patients with type 2 diabetes in Jordan: Prevalence, pattern, and associated factors. Frontiers in Public Health. 10. 1002466–1002466. 15 indexed citations
9.
Al‐Qerem, Walid, et al.. (2021). Exploring variables associated with medication non-adherence in patients with type 2 diabetes mellitus. PLoS ONE. 16(8). e0256666–e0256666. 17 indexed citations
10.
Hyassat, Dana, et al.. (2021). The prevalence of hypertension and its progression among patients with type 2 diabetes in Jordan. Annals of Medicine and Surgery. 73. 103162–103162. 10 indexed citations
12.
Naser, Abdallah Y., Ian Chi Kei Wong, Cate Whittlesea, et al.. (2018). Use of multiple antidiabetic medications in patients with diabetes and its association with hypoglycaemic events: a case-crossover study in Jordan. BMJ Open. 8(11). e024909–e024909. 12 indexed citations
14.
Kasabri, Violet, et al.. (2017). Impact of clinical pharmacists intervention on management of hyperglycemia in pregnancy in Jordan. International Journal of Clinical Pharmacy. 40(1). 48–55. 12 indexed citations
15.
Khawaja, Nahla, et al.. (2016). Vitamin D Dosing Strategies Among Jordanians With Hypovitaminosis D. Journal of Pharmacy Practice. 30(2). 172–179. 3 indexed citations
16.
Lafi, Zainab, Yacoub M. Irshaid, Mohammed El‐Khateeb, Kamel Ajlouni, & Dana Hyassat. (2015). Association of rs7041 and rs4588 Polymorphisms of the Vitamin D Binding Protein and the rs10741657 Polymorphism of CYP2R1 with Vitamin D Status Among Jordanian Patients. Genetic Testing and Molecular Biomarkers. 19(11). 629–636. 42 indexed citations
17.
Hyassat, Dana, et al.. (2015). Are insulin analogues an unavoidable necessity for the treatment of type 2 diabetes in developing countries? The case of Jordan. Eastern Mediterranean Health Journal. 21(10). 729–735. 2 indexed citations
18.
El‐Khateeb, Mohammed, Yousef Khader, Anwar Batieha, et al.. (2014). Vitamin B<sub>12</sub> Deficiency in Jordan: A Population-Based Study. Annals of Nutrition and Metabolism. 64(2). 101–105. 20 indexed citations
19.
Hyassat, Dana, et al.. (2014). Prevalence of Hypomagnesaemia among Obese Type 2 Diabetic Patients Attending the National Center for Diabetes, Endocrinology and Genetics (NCDEG). International Journal of Endocrinology and Metabolism. 12(3). e17796–e17796. 21 indexed citations
20.
Batieha, Anwar, et al.. (2011). Vitamin D Status in Jordan: Dress Style and Gender Discrepancies. Annals of Nutrition and Metabolism. 58(1). 10–18. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026